Initiate a Phase 1b/2 clinical trial for AP-SA02
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 27 Jan 2021
- Due
- 31 Dec 2021
- Checked
- 25 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“the Company expects to initiate a second clinical trial related to another product candidate, AP-SA02, a phage targeting Staphylococcus aureus, in patients with complicated bacteremia later this year.”
What we found
Evidence strength A What the grades mean
While Armata received FDA IND clearance for AP-SA02 in November 2021, filings from 2022 and 2023 continue to describe the initiation of the clinical trial as a future intention.
-
A Armata Pharmaceuticals, Inc. 10-K filed 2023-03-16
“We intend to: ... ●Initiate and advance clinical trials of AP-SA02 in patients with S. aureus bacteremia.” ✓ confirmed on the page
Market reaction: the shares moved +3.9% against the S&P 500 over the three sessions around the disclosure (15 Mar 2023 to 20 Mar 2023). What this measures
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- AP-SA02 clinical trial
- Language
- Aspirational (“aims”, “intends”)
- In the company’s control
- High
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “no_evidence”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Armata Pharmaceuticals, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ARMP-022467 · Corrections policy